دورية أكاديمية
Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea.
| العنوان: | Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea. |
|---|---|
| المؤلفون: | Yoshiya Tanaka, Sang-Cheol Bae, Bass, Damon, Curtis, Paula, Chu, Myron, DeRose, Kathleen, Ji, Beulah, Kurrasch, Regina, Lowe, Jenny, Meizlik, Paige, Roth, David A. |
| المصدر: | RMD Open; Jun2021, Vol. 7 Issue 2, p1-11, 11p |
| قاعدة البيانات: | Complementary Index |
Full Text Finder | تدمد: | 20565933 |
|---|---|
| DOI: | 10.1136/rmdopen-2021-001629 |